“For the tens of millions of Americans who endure the pain and disabling effects of migraine disease, we congratulate Amgen and Novartis on the FDA approval of erenumab. This new class of medicine is the first to be developed and approved for the prevention of migraine attacks. We now call on all stakeholders in healthcare…Read More
The voice of migraine patients must be heard!
ICER is evaluating the new CGRP inhibitor medicines and they have refused our request to have a migraine patient or a headache specialist on the voting panel. They must hear from patients via written submissions so that the voting panel understands the pain, disability and burden of migraine disease and the desperate need for access to more effective treatments.
A new short documentary is looking for people willing to share their story of how they manage their diseases and live their lives. The casting call is open to people in the Greater New York City Area.Read More
By Honor Whiteman | Fact checked by Jasmin Collier Migraine is one of the most common and debilitating conditions in the United States. While there are therapies that can help to manage migraine, not all patients respond. A new study finds that ketamine, which is a drug primarily used as an anesthetic, could offer an alternative treatment. >>>…Read More
National Migraine and Headache Awareness Month (MHAM) is now recognized as a National Health Observance by the federal government. Healthfinder.gov keeps an official list of all the federally recognized health months, weeks and days throughout the year, and MHAM has now been added to this list for the month of June. Thanks to Chronic Migraine…Read More
Background: The Institute for Clinical and Economic Review (ICER) is assessing a new migraine treatment option to determine if it is cost-effective. The medicine, erenumab, is the first CGRP submitted for FDA approval, and a regulatory decision is expected in May 2018. Purpose: Insurance companies will use ICER’s final report (as well as other information) when determining…Read More
The American Migraine Foundation launched the Move Against Migraine initiative to mobilize and empower those living with migraine. Our goal is to create a platform for those living with migraine to advocate on behalf of themselves, understand treatment options, access resources to manage migraine symptoms and connect with leading doctors and researchers. Through our movement…Read More
By Dr. William B. Young—June 5, 2016 The words and phrases we use subtly influence how we and others think about the world. This matters a lot for migraine. It is hard to change people’s preconceived, ignorant notions and arguments just don’t have much of an impact. I’ve been arguing for a long time, and I don’t…Read More